Moreover, the data unveiled in the not-so-distant future will be an essential piece for monitoring and quantifying PSA, a useful diagnostic tool for identifying prostate cancer early on—which is the most frequent malignancy in males worldwide—and therefore aids in monitoring public concerns about the health of men. Here, KLK3 is linked to prostate carcinoma.